Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TPST

Tempest Therapeutics Inc

May 22 • 04:00PM ET

1.86

+0.05 2.76 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: NVCT CUE BLRX IMNN VERU

| Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.21	Insider Own	43.33%	Shs Outstand	14.34M	Perf Week	1.64%
Market Cap	27.54M	Forward P/E	-	EPS next Y	-1.21	Insider Trans	3.74%	Shs Float	8.39M	Perf Month	3.33%
Enterprise Value	33.59M	PEG	-	EPS next Q	-0.30	Inst Own	3.27%	Short Float	4.71%	Perf Quarter	-22.50%
Income	-43.10M	P/S	-	EPS this Y	78.83%	Inst Trans	-0.03%	Short Ratio	1.92	Perf Half Y	-60.84%
Sales	0.00M	P/B	32.46	EPS next Y	9.70%	ROA	-200.87%	Short Interest	0.40M	Perf YTD	-35.19%
Book/sh	0.06	P/C	15.30	EPS next 5Y	48.00%	ROE	-721.00%	52W High	12.23 -84.79%	Perf Year	-70.43%
Cash/sh	0.12	P/FCF	-	EPS past 3/5Y	46.00% 76.03%	ROIC	-579.51%	52W Low	1.50 24.00%	Perf 3Y	-93.35%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.41% 7.29%	Perf 5Y	-99.17%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	65.65%	Oper. Margin	-	ATR (14)	0.16	Perf 10Y	-99.99%
Dividend Ex-Date	-	Quick Ratio	0.74	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	47.91	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.74	EPS Q/Q	19.80%	SMA20	-2.54%	Beta	-1.76	Target Price	11.00
Payout	-	Debt/Eq	9.57	Sales Q/Q	-	SMA50	-1.91%	Rel Volume	0.29	Prev Close	1.81
Employees	4	LT Debt/Eq	8.07	Earnings	May 14 AMC	SMA200	-64.29%	Avg Volume	205.46K	Price	1.86
IPO	Nov 12, 2012	Option/Short	No / Yes	EPS/Sales Surpr.	-803.57% -	Trades		Volume	58,834	Change	2.76%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)